Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)
21.85 x 1 21.92 x 15
Post-market by (Cboe BZX)
21.91 +0.32 (+1.48%) 04/11/25 [NYSE]
21.85 x 1 21.92 x 15
Post-market 21.90 -0.01 (-0.05%) 19:59 ET
Profile for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Pfizer Inc 66 HUDSON BOULEVARD EAST NEW YORK NY 10001 USA

www.pfizer.com Employees: 81,000 P: 212-733-2323

Sector:

Medical

Description:

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.'The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.

Key Statistics

Overview:

Market Capitalization, $K 122,446,720
Enterprise Value, $K 185,754,720
Shares Outstanding, K 5,671,455
Annual Sales, $ 63,627 M
Annual Net Income, $ 8,031 M
Last Quarter Sales, $ 17,763 M
Last Quarter Net Income, $ 410,000 K
EBIT, $ 17,697 M
EBITDA, $ 24,710 M
60-Month Beta 0.67
% of Insider Shareholders 0.06%
% of Institutional Shareholders 68.36%
Float, K 5,668,052
% Float 99.94%
Short Volume Ratio 0.53

Growth:

1-Year Return -16.82%
3-Year Return -58.75%
5-Year Return -40.64%
5-Year Revenue Growth 22.95%
5-Year Earnings Growth 5.42%
5-Year Dividend Growth 16.67%

Per-Share Information:

Most Recent Earnings 0.63 on 02/04/25
Next Earnings Date 04/29/25 [BMO]
Earnings Per Share ttm 3.11
EPS Growth vs. Prev Qtr -40.57%
EPS Growth vs. Prev Year 530.00%
Annual Dividend Rate, $ 1.69
Annual Dividend Yield 7.83%
Most Recent Dividend 0.430 on 01/24/25
Next Ex-Dividends Date 01/24/25
Dividend Payable Date 03/07/25
Dividend Payout Ratio 53.71%
Most Recent Split 3-1 on 07/01/99

PFE Ratios

Ratio
Price/Earnings ttm 7.23
Price/Earnings forward 7.54
Price/Earnings to Growth 0.55
Return-on-Equity % 19.60%
Return-on-Assets % 8.15%
Profit Margin % 12.62%
Debt/Equity 0.73
Price/Sales 2.00
Price/Cash Flow 5.15
Price/Book 1.44
Book Value/Share 15.62
Interest Coverage -1.47

PFE Dividends

Date Value
01/24/25 $0.4300
11/08/24 $0.4200
07/26/24 $0.4200
05/09/24 $0.4200
01/25/24 $0.4200
11/09/23 $0.4100
07/27/23 $0.4100
05/11/23 $0.4100
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.